Carvedilol Tablet, Film Coated
Product Images NDC 55154-2649

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 55154-2649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

25mg Bag Label (Bd0f2596 A192 4b0e 836f 4a09816408a4 00)

25mg Bag Label (Bd0f2596 A192 4b0e 836f 4a09816408a4 00)
This is a description of Carvedilol tablets, USP, with a dosage of 25 mg per tablet. The usual dosage instructions and storage recommendations are provided. It states that the product must be stored at a temperature range of 20°C to 25°C. The package is a Unit Dose package that is not child-resistant and is intended for institutional use only. The tablets are dispensed in a tight container and the product meets USP Dissolution Test 2 standards. The drug product is from NDC # 68462165 by Glenmark Pharmaceuticals Inc., USA. It is packaged and distributed by Major Pharmaceuticals in Indianapolis, USA. The distribution is managed by Cardinal Health in Dublin, Ohio. More detailed prescribing information, precautions, and warnings can be found in the product insert.*
FDA Label Image

3.125mg Bag Label (Bd0f2596 A192 4b0e 836f 4a09816408a4 01)

3.125mg Bag Label (Bd0f2596 A192 4b0e 836f 4a09816408a4 01)
This is a description of Carvedilol Tablets, USP, containing 3.125 mg of Carvedilol per tablet. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) in a tightly closed container to protect from moisture. The product is for prescription use only and should be kept out of reach of children due to the packaging not being child-resistant. Safety closures should be used during dispensing unless otherwise directed by a physician. The tablets meet USP Dissolution Test 2 standards. The drug product is from NDC #68462-162 by Glenmark Pharmaceuticals Inc., USA, and packaged by Major® Pharmaceuticals and distributed by Cardinal Health.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This text provides information about a study comparing placebo to Carvedilol, with a p-value of 0.0014. The numbers 3, 6, 9, 12, 15, 18, and 21 may refer to specific time points within the study.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This text appears to be a table presenting various factors such as gender, age, race, medical conditions (diabetes, heart issues), and medication usage in a research or medical context. The table possibly includes information on heart rate, blood pressure, and specific medication like spironolactone. There is also a reference to hazard ratio, which may be related to statistical analysis.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
This text provides information on mortality statistics from a study named CAPRICORN, specifically focusing on survival analysis. The study compares the effects of a placebo treatment versus carvedilol medication. The results show that carvedilol treatment has a significant impact on survival rates with a p-value of 0.03.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This text provides detailed information on the effects of mortality for different subgroups in the CAPRICORN study. The effects were analyzed based on factors such as age, gender, diuretic use, onset of myocardial infarction (MI), angina presence, hypertension status, beta-blocker use, diabetes, Killip class, heart rate, thrombolytic therapy, systolic blood pressure (SBP), and percutaneous transluminal coronary angioplasty (PTCA). The data presented includes hazard ratios for each subgroup, shedding light on mortality outcomes post-MI.*
FDA Label Image
Logo (Logo)
FDA Label Image

Logo1 (Logo1)

Logo1 (Logo1)
FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.